WILSON TROY EDWARD (President and CEO) received a stock award from KURA ONCOLOGY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/14/2025ACC: 0001193125-25-283565
DirectorOfficer· President and CEO
Since Nov 2018
+182.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
182.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+182.50K
Price / share
—
Trade value
—
% of position
73.9%
11/13/2025
246.85K→429.35K
Total
Net shares
+182.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/13/2025 | A · Award | +182.50K | — | — | 73.9% | 246.85K | 429.35K |
| Total | +182.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned279.19K
Common Stock
IndirectShares owned300K
Total
579.19K indirect579.19K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 279.19K | Indirect |
| Common Stock | 300K | Indirect |
| Total | 579.19K | 579.19K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported